Aronia melanocarpa and its components demonstrate antiviral activity against influenza viruses

Biochemical and Biophysical Research Communications

Volumn 440, Issue 1, 2013, Pages 14-19

  Park, Sehee ^a   Kim, Jin Il ^a   Lee, Ilseob ^a   Lee, Sangmoo ^a   Hwang, Min Woong ^a   Bae, Joon Yong ^a   Heo, Jun ^a   Kim, Donghwan ^a   Han, Sang Zin ^a   Park, Man Seong ^a  

^a Hallym University   (South Korea)

Author keywords

Antiviral; Influenza virus; Polyphenol; Therapeutics

Indexed keywords

ANTIVIRUS AGENT; ARONIA MELANOCARPA EXTRACT; CHEMICAL COMPOUND; ELLAGIC ACID; MYRICETIN; OSELTAMIVIR; PLANT EXTRACT; POLYPHENOL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARONIA MELANOCARPA; ARTICLE; CHEMICAL COMPOSITION; DRUG CYTOTOXICITY; HEMAGGLUTINATION INHIBITION; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA VIRUS; INFLUENZA VIRUS A H5N1; MEDICINAL PLANT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHRUB; VIRUS STRAIN;

ANTIVIRAL; INFLUENZA VIRUS; POLYPHENOL; THERAPEUTICS;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DRUG RESISTANCE, VIRAL; ELLAGIC ACID; FEMALE; FLAVONOIDS; FRUIT; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; OSELTAMIVIR; PHOTINIA; PLANT EXTRACTS; POLYPHENOLS; VIRUS REPLICATION;

ARONIA; MUS; ORTHOMYXOVIRIDAE; PHOTINIA MELANOCARPA;

EID: 84885380653     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.08.090     Document Type: Article

References (35)

1. Orthomyxoviruses 2007, Lippincott Williams & Wilkins, Philadephia. P. Wright, G. Neumann, Y. Kawaoka (Eds.).
2. Palese P. Influenza: old and new threats. Nat. Med. 2004, 10:S82-87.
3. Dawood F.S., Iuliano A.D., Reed C., Meltzer M.I., Shay D.K., Cheng P.Y., Bandaranayake D., Breiman R.F., Brooks W.A., Buchy P., Feikin D.R., Fowler K.B., Gordon A., Hien N.T., Horby P., Huang Q.S., Katz M.A., Krishnan A., Lal R., Montgomery J.M., Molbak K., Pebody R., Presanis A.M., Razuri H., Steens A., Tinoco Y.O., Wallinga J., Yu H., Vong S., Bresee J., Widdowson M.A. Estimated global mortality associated with the first 12 months of 2009 Pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect. Dis. 2009, 12:687-695.
4. Izurieta H.S., Thompson W.W., Kramarz P., Shay D.K., Davis R.L., DeStefano F., Black S., Shinefield H., Fukuda K. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N. Engl. J. Med. 2000, 342:232-239.
5. Jefferson T., Rivetti D., Rivetti A., Rudin M., Di Pietrantonj C., Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005, 366:1165-1174.
6. Osterholm M.T., Kelley N.S., Sommer A., Belongia E.A. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect. Dis. 2012, 12:36-44.
7. Della Cioppa G., Vesikari T., Sokal E., Lindert K., Nicolay U. Trivalent and quadrivalent MF59((R))-adjuvanted influenza vaccine in young children: a dose- and schedule-finding study. Vaccine 2011, 29:8696-8704.
8. Song J.H., Nguyen H.H., Cuburu N., Horimoto T., Ko S.Y., Park S.H., Czerkinsky C., Kweon M.N. Sublingual vaccination with influenza virus protects mice against lethal viral infection. Proc. Natl. Acad. Sci. USA 2008, 105:1644-1649.
9. Gilbert S.C. Advances in the development of universal influenza vaccines. Influenza Other Respi. Viruses 2012, 7:750-758.
10. Das K., Aramini J.M., Ma L.C., Krug R.M., Arnold E. Structures of influenza A proteins and insights into antiviral drug targets. Nat. Struct. Mol. Biol. 2010, 17:530-538.
11. Tamura D., Sugaya N., Ozawa M., Takano R., Ichikawa M., Yamazaki M., Kawakami C., Shimizu H., Uehara R., Kiso M., Kawakami E., Mitamura K., Kawaoka Y. Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitors. Clin. Infect. Dis. 2011, 52:432-437.
12. Kiso M., Ozawa M., Le M.T., Imai H., Takahashi K., Kakugawa S., Noda T., Horimoto T., Kawaoka Y. Effect of an asparagine-to-serine mutation at position 294 in neuraminidase on the pathogenicity of highly pathogenic H5N1 influenza A virus. J. Virol. 2011, 85:4667-4672.
13. Kiso M., Shinya K., Shimojima M., Takano R., Takahashi K., Katsura H., Kakugawa S., Le M.T., Yamashita M., Furuta Y., Ozawa M., Kawaoka Y. Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses. PLoS Pathog. 2010, 6:e1001079.
14. Nakayama M., Suzuki K., Toda M., Okubo S., Hara Y., Shimamura T. Inhibition of the infectivity of influenza virus by tea polyphenols. Antiviral Res. 1993, 21:289-299.
15. Droebner K., Ehrhardt C., Poetter A., Ludwig S., Planz O. CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in mice. Antiviral Res. 2007, 76:1-10.
16. Valcheva-Kuzmanova S.V., Belcheva A. Current knowledge of Aronia melanocarpa as a medicinal plant. Folia Med. (Plovdiv) 2006, 48:11-17.
17. Kulling S.E., Rawel H.M. Chokeberry (Aronia melanocarpa) - a review on the characteristic components and potential health effects. Planta Med. 2008, 74:1625-1634.
18. Kim Y., Narayanan S., Chang K.O. Inhibition of influenza virus replication by plant-derived isoquercetin. Antiviral Res. 2010, 88:227-235.
19. Jeong H.J., Ryu Y.B., Park S.J., Kim J.H., Kwon H.J., Park K.H., Rho M.C., Lee W.S. Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities. Bioorg. Med. Chem. 2009, 17:6816-6823.
20. Hirabayashi T., Ochiai H., Sakai S., Nakajima K., Terasawa K. Inhibitory effect of ferulic acid and isoferulic acid on murine interleukin-8 production in response to influenza virus infections in vitro and in vivo. Planta Med. 1995, 61:221-226.
21. Pollikoff R., Liberman M., Cochran K.W., Pascale A.M. Effect of caffeic acid on mouse and ferret lung infected with influenza A virus. Antimicrob. Agents Chemother. (Bethesda) 1965, 5:561-566.
22. Zhang L., Cheng Y.X., Liu A.L., Wang H.D., Wang Y.L., Du G.H. Antioxidant, anti-inflammatory and anti-influenza properties of components from Chaenomeles speciosa. Molecules 2010, 15:8507-8517.
23. Haidari M., Ali M., Ward Casscells S., Madjid, M. Pomegranate (Punica granatum) purified polyphenol extract inhibits influenza virus and has a synergistic effect with oseltamivir. Phytomedicine 2009, 16:1127-1136.
24. Davies W.L., Grunert R.R., Haff R.F., McGahen J.W., Neumayer E.M., Paulshock M., Watts J.C., Wood T.R., Hermann E.C., Hoffmann C.E. Antiviral Activity of 1-Adamantanamine. Science 1964, 144:862-863.
25. Kim J.I., Lee I., Park S., Park M.S. Surface glycoproteins determine the feature of the pandemic H1N1 virus. BMB Rep. 2009, 45(2012):653-658.
26. Kim J.I., Park S., Lee I., Lee S., Shin S., Won Y., Hwang M.W., Bae J.Y., Heo J., Hyun H.E., Jun H., Lim S.S., Park M.S. GFP-expressing influenza A virus for evaluation of the efficacy of antiviral agents. J. Microbiol. 2012, 50:359-362.
27. Hakkinen S.H., Heinonen I.M., Karenlampi S.O., Mykkanen H.M., Ruuskanen J., Torronen A.R. Screening of selected flavonoids and phenolic acids in 19 berries. Food Res. Int. 1999, 32:345-353.
28. Manicassamy B., Manicassamy S., Belicha-Villanueva A., Pisanelli G., Pulendran B., Garcia-Sastre A. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc. Natl. Acad. Sci. USA 2010, 107:11531-11536.
29. Vauzour D., Rodriguez-Mateos A., Corona G., Oruna-Concha M.J., Spencer J.P. Polyphenols and human health: prevention of disease and mechanisms of action. Nutrients 2010, 2:1106-1131.
30. Rodriguez Vaquero M.J., Aredes Fernandez P.A., Manca de Nadra M.C., Strasser de Saad A.M. Phenolic compound combinations on Escherichia coli viability in a meat system. J. Agric. Food Chem. 2010, 58:6048-6052.
31. Daglia M. Polyphenols as antimicrobial agents. Curr. Opin. Biotechnol. 2012, 23:174-181.
32. Kim J.I., Lee I., Park S., Hwang M.W., Bae J.Y., Lee S., Heo J., Park M.S., Garcia-Sastre A., Park M.S. Genetic requirement for hemagglutinin glycosylation and its implications for influenza A H1N1 virus evolution. J. Virol. 2013, 87:7539-7549.
33. Ono K., Nakane H., Fukushima M., Chermann J.C., Barre-Sinoussi F. Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases. Eur. J. Biochem. 1990, 190:469-476.
34. Fioravanti R., Celestino I., Costi R., Cuzzucoli Crucitti G., Pescatori L., Mattiello L., Novellino E., Checconi P., Palamara A.T., Nencioni L., Di Santo R. Effects of polyphenol compounds on influenza A virus replication and definition of their mechanism of action. Bioorg. Med. Chem. 2012, 20:5046-5052.
35. Mendel D.B., Roberts N.A. In-vitro and in-vivo efficacy of influenza neuraminidase inhibitors. Curr. Opin. Infect. Dis. 1998, 11:727-732.